$84.9 B

BMY Mkt cap, 04-Dec-2018

$5.7 B

Bristol-Myers Squibb Revenue Q3, 2018
Bristol-Myers Squibb Gross profit (Q3, 2018)4 B
Bristol-Myers Squibb Gross profit margin (Q3, 2018), %71%
Bristol-Myers Squibb Net income (Q3, 2018)1.9 B
Bristol-Myers Squibb Cash, 30-Sep-20185.4 B
Bristol-Myers Squibb EV85.2 B

Bristol-Myers Squibb Revenue

Bristol-Myers Squibb revenue was $20.78 b in FY, 2017

Embed Graph

Bristol-Myers Squibb Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

16.4b15.9b16.6b19.4b20.8b

Revenue growth, %

(3%)4%17%

Cost of goods sold

4.6b3.9b3.9b4.9b6.1b

Gross profit

11.8b11.9b12.7b14.5b14.7b

Gross profit Margin, %

72%75%76%75%71%

R&D expense

6.4b

Operating expense total

15.6b

Pre tax profit

2.9b2.4b2.1b5.9b5.1b

Income tax expense

311.0m352.0m446.0m1.4b4.2b

Net Income

2.6b2.0b1.6b4.5b975.0m

Bristol-Myers Squibb Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

3.6b5.6b2.4b4.2b5.4b

Accounts Receivable

6.3b

Inventories

1.5b1.6b1.2b1.2b1.2b

Current Assets

18.9b14.6b10.4b13.7b14.9b

Goodwill

7.1b7.0b6.9b6.9b6.9b

Total Assets

38.6b33.7b31.7b33.7b33.6b

Accounts Payable

2.6b2.5b1.6b1.7b2.2b

Dividends Payable

634.0m645.0m655.0m

Short-term debt

359.0m590.0m139.0m992.0m

Current Liabilities

12.4b8.5b8.0b8.8b9.6b

Long-term debt

8.0b7.2b6.6b5.7b7.0b

Total Debt

8.3b7.8b6.7b6.7b7.0b

Total Liabilities

21.7b

Retained Earnings

33.0b32.5b31.6b33.5b31.2b

Total Equity

15.2b15.0b14.4b16.3b11.8b

Debt to Equity Ratio

0.5 x0.5 x0.5 x0.4 x

Debt to Assets Ratio

0.2 x0.2 x0.2 x0.2 x

Financial Leverage

2.5 x2.3 x2.2 x2.1 x2.8 x

Bristol-Myers Squibb Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

2.6b2.0b1.6b4.5b975.0m

Accounts Receivable

(431.0m)

Inventories

(45.0m)(254.0m)97.0m(152.0m)(29.0m)

Accounts Payable

412.0m(44.0m)(919.0m)104.0m320.0m

Cash From Operating Activities

3.5b3.1b1.8b2.9b5.3b

Cash From Investing Activities

(572.0m)1.2b(1.6b)1.5b(66.0m)

Long-term Borrowings

(597.0m)(676.0m)(2.0b)(15.0m)(1.2b)

Cash From Financing Activities

(1.1b)(2.4b)(3.4b)(2.4b)(4.1b)

Free Cash Flow

2.7b4.1b4.2b

Bristol-Myers Squibb Ratios

USDY, 2018

EV/CFO

24.3 x

Debt/Equity

0.4 x

Debt/Assets

0.2 x

Financial Leverage

2.5 x
Report incorrect company information

Bristol-Myers Squibb Operating Metrics

FY, 2015FY, 2016

Phase III Trials Products

2 8

Projects in R&D Pipeline

32 44
Report incorrect company information

Bristol-Myers Squibb Employee Rating

3.61569 votes
Culture & Values
3.7
Work/Life Balance
3.7
Senior Management
3.1
Salary & Benefits
3.8
Career Opportunities
3.2
Source